Paul Gross
Director/Board Member chez Clovis Oncology UK Ltd.
Profil
Paul Edward Gross is currently a Director at Clovis Oncology UK Ltd.
He previously worked as a Director of Business Operations at Oracle Corp.
and as a General Counsel at Datalogix Holdings, Inc. He was also a Partner at Cooley LLP for 12 years.
In addition, he was a Founding Partner at Gross Cutler Seiler Dupont LLC.
He received his undergraduate degree from the United States Naval Academy and his graduate degree from UC Davis School of Law.
Currently, he holds the position of Secretary, Executive VP & General Counsel at Clovis Oncology, Inc.
Postes actifs de Paul Gross
| Sociétés | Poste | Début |
|---|---|---|
Clovis Oncology UK Ltd.
 Clovis Oncology UK Ltd. BiotechnologyHealth Technology Part of Clovis Oncology, Inc., Clovis Oncology UK Ltd. is a private company that engages in research and development on biotechnology. Clovis Oncology UK Ltd. is based in Cambridge, UK. | Director/Board Member | - |
Anciens postes connus de Paul Gross
| Sociétés | Poste | Fin |
|---|---|---|
| CLOVIS ONCOLOGY, INC. | Compliance Officer | 01/02/2020 |
| ORACLE CORPORATION | Chief Operating Officer | 01/01/2016 |
Datalogix Holdings, Inc.
 Datalogix Holdings, Inc. Advertising/Marketing ServicesCommercial Services Datalogix Holdings, Inc. provides database marketing and digital media solutions. It offers core infrastructure for data-driven marketing by connecting digital advertising to offline sales. The firm serves the retail, automotive, consumer packaged goods, and financial sectors. The company was founded by Robert W. Gierkink and Tim Wright in 2002 and is headquartered in Westminster, CO. | General Counsel | 31/12/2015 |
| DataLogix, Inc. | General Counsel | 01/01/2015 |
| Gross Cutler Seiler Dupont LLC | Corporate Officer/Principal | 01/02/2014 |
Formation de Paul Gross
| United States Naval Academy | Undergraduate Degree |
| UC Davis School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORACLE CORPORATION | Technology Services |
| Entreprise privées | 6 |
|---|---|
Datalogix Holdings, Inc.
Datalogix Holdings, Inc. Advertising/Marketing ServicesCommercial Services Datalogix Holdings, Inc. provides database marketing and digital media solutions. It offers core infrastructure for data-driven marketing by connecting digital advertising to offline sales. The firm serves the retail, automotive, consumer packaged goods, and financial sectors. The company was founded by Robert W. Gierkink and Tim Wright in 2002 and is headquartered in Westminster, CO. | Commercial Services |
Cooley LLP
 Cooley LLP Miscellaneous Commercial ServicesCommercial Services Cooley LLP engages in the provision of legal services. It offers strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. Its practices include commercial litigation; patent counseling and prosecution; employment and labor; asset recovery; and estate planning and personal representation. The company was founded in 1920 and is headquartered in New York, NY. | Commercial Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of innovative anti-cancer agents in the United States, Europe, and additional international markets. Its U.S. marketed product, Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is approved for use in the maintenance treatment and treatment of eligible adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC), which have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. In Europe, Rubraca is approved for use in recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO. | Health Technology |
| DataLogix, Inc. | Commercial Services |
| Gross Cutler Seiler Dupont LLC | |
Clovis Oncology UK Ltd.
Clovis Oncology UK Ltd. BiotechnologyHealth Technology Part of Clovis Oncology, Inc., Clovis Oncology UK Ltd. is a private company that engages in research and development on biotechnology. Clovis Oncology UK Ltd. is based in Cambridge, UK. | Health Technology |
